Aclidinium, a dual-action compound, serves as a long-acting muscarinic antagonist and a beta2-adrenoceptor (beta2-AR) agonist, exhibiting bronchodilator properties. It effectively reduces lung hyperinflation, enhances lung function, and prolongs exercise endurance time. This compound is commonly utilized in studies focusing on chronic obstructive pulmonary disease (COPD).
Molecular Weight:
484.65
CAS Number:
[727649-81-2]
Formula:
C26H30NO4S2
Target:
Adrenergic Receptor
T200043
* VAT and and shipping costs not included. Errors and price changes excepted
